GlassScriptPhysician profile
Michael G Deguzman
NPI 1235202144
$801.08
in general payments reported to CMS, 2019-2025
15 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6.12 · 2022: $124 · 2023: $163 · 2024: $193 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $120.43 | 2025 | Cobenfy |
| Bayer Healthcare Pharmaceuticals INC. | $116.58 | 2023-2025 | |
| Amgen INC. | $110.77 | 2023-2024 | Otezla, Repatha |
| Phadia US INC. | $86.31 | 2022-2024 | Immunocap |
| Hologic Sales and Service, LLC | $76.09 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Sanofi Pasteur INC. | $64.57 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $61.94 | 2022 | |
| Sanofi-Aventis U.S. LLC | $37.83 | 2025 | |
| International Rehabilitative Sciences, INC | $29.07 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Lilly USA, LLC | $27.12 | 2025 | Mounjaro, Zepbound |
| Medline Industries LP | $24.26 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.45 | 2022 | |
| Exact Sciences Corporation | $14.51 | 2025 | The Cologuard Plus Collection Kit |
| Genentech USA, INC. | $6.12 | 2021 | |
| New World Medical,INC. | $6.03 | 2025 | Streamline, Via360, Ahmed Glaucoma Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Deguzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.